Zenotech Laboratories Limited (BOM:532039)

India flag India · Delayed Price · Currency is INR
35.39
-2.95 (-7.69%)
At close: Mar 27, 2026
Market Cap2.16B -35.7%
Revenue (ttm)419.33M +16.5%
Net Income33.62M -32.6%
EPS0.55 -32.9%
Shares Out61.03M
PE Ratio64.37
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume70,458
Average Volume21,399
Open38.00
Previous Close38.34
Day's Range34.50 - 38.00
52-Week Range34.99 - 72.87
Beta-0.17
RSI31.92
Earnings DateApr 27, 2026

About Zenotech Laboratories

Zenotech Laboratories Limited manufactures and markets pharmaceutical specialty generic injectables in the oncology and anesthesiology markets in India. It offers contract manufacturing services for parenteral depot formulations, ophthalmic, oncology oral and injectables, and general injectables. The company also leases out its biotech facility and equipment. In addition, it provides granulocyte-colony stimulating factor and granulocyte-macrophage colony-stimulating factor products. Zenotech Laboratories Limited was incorporated in 1989 and is ... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1989
Employees 228
Stock Exchange Bombay Stock Exchange
Ticker Symbol 532039
Full Company Profile

Financial Performance

In fiscal year 2025, Zenotech Laboratories's revenue was 390.98 million, an increase of 6.22% compared to the previous year's 368.09 million. Earnings were 56.13 million, a decrease of -32.36%.

Financial Statements